Pirfenidone in Unclassifiable Interstitial Lung Disease (uILD): A Subgroup Analysis Stratified by Concomitant Mycophenolate Mofetil (MMF) Use

Autor:	Toby M. Maher, Frank Gilberg, Vincent Cottin, Judit Axmann, Tamera J. Corte, Michael Kreuter, Klaus-Uwe Kirchgaessler, Maria Molina-Molina
Rok vydání:	2020
Předmět:	medicine.medical_specialty business.industry Internal medicine Concomitant Interstitial lung disease medicine Subgroup analysis Pirfenidone medicine.disease Mycophenolate business Gastroenterology medicine.drug
Zdroj:	C22. ILD THERAPY III.
DOI:	10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4557
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6c8e6c9b3755917a6016722be0d88e75 https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4557 Zobrazit plný text záznamu